Melanin Correction Is Essential for Quantitative Autofluorescence-Based Measurement of Macular Pigment

Macular pigment optical density (MPOD) is widely measured by dual-wavelength autofluorescence imaging (AFI) because the method is noninvasive, image-based, and clinically practical. AFI-derived MPOD and macular pigment optical volume (MPOV) are increasingly used as retinal biomarkers in clinical research, supplementation studies, disease-risk interpretation, and population-based comparisons. However, conventional dual-wavelength AFI assumes that posterior absorbers other than macular pigment (MP), particularly melanin, are negligible or sufficiently stable not to bias the measurement. This assumption may limit the diagnostic and biomarker reliability of AFI-derived MP metrics. This manuscript presents a focused biological, optical, and mathematical analysis of AFI-based MP quantification. The foundational AFI literature, the melanin imaging literature, retinal pigment epithelium (RPE) pigment biology, and related optical modeling concepts were examined to evaluate where melanin enters the AFI signal pathway, how it may confound MPOD and MPOV, and how a melanin-sensitive baseline could improve quantitative specificity within the AFI domain. Conventional dual-wavelength AFI estimates MP indirectly from attenuation of RPE lipofuscin autofluorescence under excitation wavelengths that differ in MP absorption. Because melanin is located in the RPE and choroid, varies with retinal location, age, and pigmentation, and can influence the same excitation and detection pathway, unmeasured melanin can become embedded in the apparent MPOD signal. Under these conditions, reported MPOD and derived MPOV are better understood as model-dependent estimates whose quantitative specificity may vary across subjects, retinal locations, devices, and studies. This has direct implications for diagnostic interpretation, normative databases, cross-subject comparison, supplementation-response studies, and biomarker-based retinal assessment. Melanin correction is not a minor refinement of AFI-based MP quantification. It is likely necessary when AFI-derived MP metrics are intended to be interpreted as quantitatively specific retinal biomarkers rather than conditionally approximate optical estimates. A melanin-corrected AFI framework, based on introducing a melanin-sensitive baseline wavelength outside the principal MP absorption range, offers a path toward more reliable MPOD and MPOV interpretation in clinical, diagnostic, and supplementation-related studies.